Publication Name	World Journal of Diabetes
Manuscript ID	70164
Country	China

Received	2021-09-02 09:07
Peer-Review Started	2021-09-02 09:10
To Make the First Decision
Return for Revision	2021-10-03 18:56
Revised	2021-10-15 04:08
Second Decision	2021-12-08 07:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-12-10 03:04
Articles in Press	2021-12-10 03:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-12-13 06:42
Publish the Manuscript Online	2021-12-16 07:46

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Retrospective Study
Article Title	Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction
Manuscript Source	Unsolicited Manuscript
All Author List	You Yu, Lin Wang, Xu Zhu, Ya-Fei Liu and Hai-Ying Ma
ORCID	Author(s) ORCID Number You Yu http://orcid.org/0000-0002-6676-5108 Lin Wang http://orcid.org/0000-0002-6482-4610 Xu Zhu http://orcid.org/0000-0002-7563-1910 Ya-Fei Liu http://orcid.org/0000-0002-1624-1349 Hai-Ying Ma http://orcid.org/0000-0002-0217-5942
Funding Agency and Grant Number
Corresponding Author	Hai-Ying Ma, MHSc, Chief Pharmacist, Department of Pharmacy, The Fourth Affiliated Hospital of China Medical University, No. 4 Chongshan Road, Huanggu District, Shenyang 110032, Liaoning Province, China. mhy2021888@163.com
Key Words	Sodium ozagrel; Atorvastatin; Type 2 diabetes; Lacunar infarction; Inflammatory response; Nerve damage
Core Tip	This study was performed to observe the effect of sodium ozagrel combined with atorvastatin on high-mobility group protein B1 and high-sensitivity C-reactive protein in patients with type 2 diabetes mellitus and lacunar infarction. The purpose was to find a treatment plan that can effectively inhibit the pathological mechanism, alleviate clinical symptoms, improve the prognosis, and guide clinical treatment.
Publish Date	2021-12-16 07:46
Citation	Yu Y, Wang L, Zhu X, Liu YF, Ma HY. Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction. World J Diabetes 2021; 12(12): 2096-2106
URL	https://www.wjgnet.com/1948-9358/full/v12/i12/2096.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i12.2096

Full Article (PDF)	WJD-12-2096.pdf
Full Article (Word)	WJD-12-2096.docx
Manuscript File	70164_Auto_Edited.docx
Answering Reviewers	70164-Answering reviewers.pdf
Audio Core Tip	70164-Audio core tip.m4a
Biostatistics Review Certificate	70164-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	70164-Conflict-of-interest statement.pdf
Copyright License Agreement	70164-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	70164-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	70164-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	70164-Language certificate.pdf
Peer-review Report	70164-Peer-review(s).pdf
Scientific Editor Work List	70164-Scientific editor work list.pdf
CrossCheck Report	70164-CrossCheck report.pdf